Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × Sulfasalazine × Clear all

Phase

Phase 2 3 Phase 3 2 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 559 pembrolizumab 434 Paclitaxel 397 Gemcitabine 383 Cisplatin 379 Carboplatin 375 Radiotherapy 339 fludarabine 318 Nivolumab 298 Bevacizumab 247 Docetaxel 241 Irinotecan 218 Magnetic Resonance Spectroscopy 213 Dexamethasone 200 Fluorouracil 199 Specimen Handling 194 Capecitabine 192 Rituximab 182 Cytarabine 181 Oxaliplatin 176 fludarabine phosphate 174 Temozolomide 171 Biopsy 171 Ipilimumab 166 Lenalidomide 162 Etoposide 162 Doxorubicin 153 Cetuximab 151 Leucovorin 150 Bortezomib 149

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04205357 2023-03-03

SAS-GKRS

Haukeland University Hospital

Phase 1 Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡